Table 5.

Subsets of biomarker-endogenous control candidates.

microRNAs changing with hemolysis			microRNAs unaffected by hemolysis
microRNA	Relative fold increase H vs. NH		microRNA	Relative fold difference H vs. NH
	N1	MPM1		N1	MPM1
let-7b	2.12 ± 0.43	14.06 ± 9.83	let-7a	1.33 ± 1.3	1.25 ± 0.71
miR-126#	2.70 ± 1.03	2.87 ± 1.00	let-7d	1.49 ± 0.77	0.97 ± 0.78
miR-140-3p	2.60 ± 0.70	10.96 ± 3.69	miR-1260	1.37 ± 1.14	1.23 ± 0.52
miR-15a#	2.92 ± 1.96	2.00 ± 1.10	miR-127	1.29 ± 0.68	0.66 ± 0.86
miR-15b#	5.40 ± 4.17	4.96 ± 2.04	miR-1274A	1.14 ± 0.27	1.20 ± 0.59
miR-16	3.55 ± 0.87	10.18 ± 0.38	miR-1274B	1.49 ± 0.39	0.87 ± 0.06
miR-193b	5.26 ± 3.39	6.16 ± 6.00	miR-130b	1.00 ± 0.38	1.10 ± 0.33
miR-194	18.14 ± 14.34	2.86 ± 2.21	miR-142-5p	1.50 ± 1.04	1.30 ± 0.43
miR-20a	2.10 ± 0.83	3.83 ± 0.37	miR-143	0.89 ± 0.47	1.09 ± 0.32
miR-20b	2.46 ± 1.80	19.24 ± 3.30	miR-146a	1.29 ± 0.14	1.49 ± 0.87
miR-21	2.57 ± 0.47	2.90 ± 0.22	miR-221	1.35 ± 0.58	1.50 ± 0.93
miR-210	2.50 ± 1.01	26.93 ± 7.48	miR-222	1.26 ± 0.45	1.38 ± 0.06
miR-26b	2.56 ± 0.48	3.58 ± 1.29	miR-27b	1.49 ± 1.40	1.27 ± 0.21
miR-320	2.25 ± 0.13	3.32 ± 0.01	miR-324-5p	1.20 ± 0.04	1.08 ± 0.90
miR-320B	2.28 ± 0.96	3.66 ± 3.50	miR-338-5P	0.76 ± 0.06	1.41 ± 0.77
miR-324-3p	3.30 ± 1.51	9.12 ± 6.61	miR-339-5p	1.29 ± 0.94	1.04 ± 0.16
miR-331-5p	3.54 ± 3.40	22.65 ± 19.81	miR-340#	0.94 ± 0.38	0.8 ± 0.53
miR-340	2.63 ± 1.43	3.71 ± 1.20	miR-425#	1.10 ± 0.83	0.96 ± 0.02
miR-425-5p	2.44 ± 0.90	4.75 ± 3.74	miR-744	0.71 ± 0.21	1.01 ± 0.31
miR-454	4.62 ± 1.19	6.15 ± 3.64
miR-484	2.11 ± 0.12	3.13 ± 0.09
miR-486-3p	2.51 ± 1.32	14.20 ± 5.57
miR-532-3p	2.50 ± 2.05	3.75 ± 2.71
miR-652	3.08 ± 2.52	3.45 ± 0.43
miR-140	2.17 ± 0.18	3.20 ± 0.56
miR-451	2.38 ± 0.84	15.27 ± 1.78